Supernus Pharmaceuticals, Inc. (LON:0LB2)
London · Delayed Price · Currency is GBP · Price in USD 51.80
+0.29 (0.56%)
At close: Dec 24, 2025
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 674 employees as of December 31, 2024. The number of employees increased by 22 or 3.37% compared to the previous year.
Employees
674
Change (1Y)
22
Growth (1Y)
3.37%
Revenue / Employee
752.26K GBP
Profits / Employee
-21.10K GBP
Market Cap
2.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 674 | 22 | 3.37% |
| Dec 31, 2023 | 652 | 40 | 6.54% |
| Dec 31, 2022 | 612 | 37 | 6.43% |
| Dec 31, 2021 | 575 | 12 | 2.13% |
| Dec 31, 2020 | 563 | 99 | 21.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Supernus Pharmaceuticals News
- 9 days ago - Stifel Raises Price Target for Supernus Pharmaceuticals (SUPN) to $55 | SUPN Stock News - GuruFocus
- 12 days ago - Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back - The Motley Fool
- 20 days ago - Supernus Pharmaceuticals, Inc. (SUPN) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript - Seeking Alpha
- 25 days ago - Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference - GlobeNewsWire
- 5 weeks ago - Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 7 weeks ago - Supernus Pharmaceuticals (SUPN) Q3 2025 Earnings Reflect Robust Growth - GuruFocus
- 7 weeks ago - Supernus Pharmaceuticals, Inc. (SUPN) Q3 2025 Earnings Call Transcript - Seeking Alpha